Article Versions Notes

Eatmann AI, Hamouda E, Hamouda H, Farouk HK, Jobran AWM, Omar AA, Madeeh AK, Al-dardery NM, Elnoamany S, Abd-Elnasser EG, et al. Potential Use of Thalidomide in Glioblastoma Treatment: An Updated Brief Overview. Metabolites. 2023; 13(4):543. https://doi.org/10.3390/metabo13040543

Eatmann, Ahmed Ismail, Esraa Hamouda, Heba Hamouda, Hossam Khaled Farouk, Afnan W. M. Jobran, Abdallah A. Omar, Alyaa Khaled Madeeh, Nada Mostafa Al-dardery, Salma Elnoamany, Eman Gamal Abd-Elnasser, and et al. 2023. "Potential Use of Thalidomide in Glioblastoma Treatment: An Updated Brief Overview" Metabolites 13, no. 4: 543. https://doi.org/10.3390/metabo13040543

Eatmann, A. I., Hamouda, E., Hamouda, H., Farouk, H. K., Jobran, A. W. M., Omar, A. A., Madeeh, A. K., Al-dardery, N. M., Elnoamany, S., Abd-Elnasser, E. G., Koraiem, A. M., Ahmed, A. A., Abouzid, M., & Karaźniewicz-Łada, M. (2023). Potential Use of Thalidomide in Glioblastoma Treatment: An Updated Brief Overview. Metabolites, 13(4), 543. https://doi.org/10.3390/metabo13040543